Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Khashab T, Hagemeister F, Romaguera JE, Fanale MA, Pro B, McLaughlin P, Rodriguez MA, Neelapu SS, Fayad L, Younes A, Feng L, Vega F, Kwak LW, Samaniego F. Khashab T, et al. Br J Haematol. 2019 May;185(4):670-678. doi: 10.1111/bjh.15814. Epub 2019 Feb 28. Br J Haematol. 2019. PMID: 30820940 Free article. Clinical Trial.
Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
Samaniego F, Hagemeister F, Romaguera JE, Fanale MA, Pro B, McLaughlin P, Rodriguez MA, Neelapu SS, Fayad L, Younes A, Feng L, Berkova Z, Khashab T, Sehgal L, Vega-Vasquez F, Kwak LW. Samaniego F, et al. Among authors: khashab t. Br J Haematol. 2015 Jun;169(6):814-23. doi: 10.1111/bjh.13367. Epub 2015 Mar 31. Br J Haematol. 2015. PMID: 25828695 Free PMC article. Clinical Trial.
HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.
Zhu H, Berkova Z, Mathur R, Sehgal L, Khashab T, Tao RH, Ao X, Feng L, Sabichi AL, Blechacz B, Rashid A, Samaniego F. Zhu H, et al. Among authors: khashab t. Mol Cancer Res. 2015 May;13(5):809-18. doi: 10.1158/1541-7786.MCR-14-0241. Epub 2015 Feb 12. Mol Cancer Res. 2015. PMID: 25678597 Free article.
Targeting nucleolin for better survival in diffuse large B-cell lymphoma.
Jain N, Zhu H, Khashab T, Ye Q, George B, Mathur R, Singh RK, Berkova Z, Wise JF, Braun FK, Wang X, Patel K, Xu-Monette ZY, Courty J, Young KH, Sehgal L, Samaniego F. Jain N, et al. Among authors: khashab t. Leukemia. 2018 Mar;32(3):663-674. doi: 10.1038/leu.2017.215. Epub 2017 Jul 10. Leukemia. 2018. PMID: 28690315 Free PMC article.
Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphoma.
Jain N, Singh S, Laliotis G, Hart A, Muhowski E, Kupcova K, Chrbolkova T, Khashab T, Chowdhury SM, Sircar A, Shirazi F, Singh RK, Alinari L, Zhu J, Havranek O, Tsichlis P, Woyach J, Baiocchi R, Samaniego F, Sehgal L. Jain N, et al. Among authors: khashab t. Blood Adv. 2020 Sep 22;4(18):4382-4392. doi: 10.1182/bloodadvances.2020001685. Blood Adv. 2020. PMID: 32926124 Free PMC article.
13 results